Helixgate https://validator.w3.org/feed/docs/rss2.html Lilly takes oral obesity race abroad with UK launch of Foundayo Massachusetts biopharma jobs, including R&D positions, fell in 2025: Report Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency Young startups miss out on biotech venture funding rebound, MassBio says Helixgate AI & Biotech Collaboration Series + Helixgate Industry Nights Roche pours $750M into Oregon manufacturing plant as obesity push expands Home Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models DC judge rejects Merck’s IRA case more than three years after it was filed Safety concerns spur FDA to again halt testing of Regenxbio gene therapy Queen bees have a disturbing way to survive pesticides FDA extends review of Capricor cell therapy; Pain drug startup to go public Capricor’s Duchenne therapy has new life after FDA grants 3-month extension Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development Cellares, a cell therapy manufacturing specialist, to lay off 100 employees STAT+: Lady Gaga and her fiancé launch a biotech startup A hidden “on switch” in human DNA has finally been decoded Fibrinogen discovery reshapes our understanding of how wounds heal REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug FDA plans to regulate generative AI Kennedy questions vaccination guidelines following Trump’s order to break up MMR Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’ Qiagen appoints new chief executive after 9-month search Pharma marketers need a share-of-answer strategy before AI spend Opinion: Medicine stopped shaking hands. We should start again Americans bought 12% less soda under new SNAP restrictions, study says Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone Adaptive model-guided protein evolution with sparse data optimizes compact eukaryotic genome editors Five-Year Brain Organoids Reveal New Insights Into Human Development Capricor investor calls for change as company awaits decision on Duchenne candidate STAT+: HHS document offers new clues to Kennedy’s vaccine plans Lab-Grown Neocortex Models Mimic Early Brain Organization From Models to Agents: The Next Phase of AI Adoption in Molecular Discovery Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths Werewolf and Ambros to tie the knot in $150M rare disease deal STAT+: Up and down the ladder: The latest comings and goings STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more Shareholder pressures Capricor; Lilly dives deeper into vaccines This week in Drug Discovery (17-21 August 2026)  Novo Nordisk starts trialing lower maintenance doses of oral Wegovy How cost and perception could reshape the GLP-1 market Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment Focal therapy for localized prostate cancer has divided physicians. Will new data change minds? “One-in-a-million” sea creature fossil preserves soft tissue for 450 million years Bonsai reconstructs tree representations for distortion-free visualization and exploration of high-dimensional data